17-70176185-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000891.3(KCNJ2):​c.1146C>T​(p.Leu382=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,613,708 control chromosomes in the GnomAD database, including 12,253 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1313 hom., cov: 32)
Exomes 𝑓: 0.12 ( 10940 hom. )

Consequence

KCNJ2
NM_000891.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.32
Variant links:
Genes affected
KCNJ2 (HGNC:6263): (potassium inwardly rectifying channel subfamily J member 2) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 17-70176185-C-T is Benign according to our data. Variant chr17-70176185-C-T is described in ClinVar as [Benign]. Clinvar id is 137988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-70176185-C-T is described in Lovd as [Benign]. Variant chr17-70176185-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNJ2NM_000891.3 linkuse as main transcriptc.1146C>T p.Leu382= synonymous_variant 2/2 ENST00000243457.4 NP_000882.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNJ2ENST00000243457.4 linkuse as main transcriptc.1146C>T p.Leu382= synonymous_variant 2/21 NM_000891.3 ENSP00000243457 P1
KCNJ2ENST00000535240.1 linkuse as main transcriptc.1146C>T p.Leu382= synonymous_variant 2/21 ENSP00000441848 P1

Frequencies

GnomAD3 genomes
AF:
0.129
AC:
19641
AN:
151876
Hom.:
1312
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.139
Gnomad AMI
AF:
0.0965
Gnomad AMR
AF:
0.187
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.114
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.0924
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.140
GnomAD3 exomes
AF:
0.136
AC:
34181
AN:
250672
Hom.:
2536
AF XY:
0.135
AC XY:
18326
AN XY:
135616
show subpopulations
Gnomad AFR exome
AF:
0.135
Gnomad AMR exome
AF:
0.230
Gnomad ASJ exome
AF:
0.124
Gnomad EAS exome
AF:
0.107
Gnomad SAS exome
AF:
0.159
Gnomad FIN exome
AF:
0.0903
Gnomad NFE exome
AF:
0.117
Gnomad OTH exome
AF:
0.135
GnomAD4 exome
AF:
0.121
AC:
176347
AN:
1461714
Hom.:
10940
Cov.:
33
AF XY:
0.121
AC XY:
87878
AN XY:
727164
show subpopulations
Gnomad4 AFR exome
AF:
0.135
Gnomad4 AMR exome
AF:
0.224
Gnomad4 ASJ exome
AF:
0.123
Gnomad4 EAS exome
AF:
0.0992
Gnomad4 SAS exome
AF:
0.159
Gnomad4 FIN exome
AF:
0.0932
Gnomad4 NFE exome
AF:
0.115
Gnomad4 OTH exome
AF:
0.124
GnomAD4 genome
AF:
0.129
AC:
19659
AN:
151994
Hom.:
1313
Cov.:
32
AF XY:
0.130
AC XY:
9641
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.139
Gnomad4 AMR
AF:
0.187
Gnomad4 ASJ
AF:
0.130
Gnomad4 EAS
AF:
0.114
Gnomad4 SAS
AF:
0.165
Gnomad4 FIN
AF:
0.0924
Gnomad4 NFE
AF:
0.115
Gnomad4 OTH
AF:
0.138
Alfa
AF:
0.128
Hom.:
966
Bravo
AF:
0.138
Asia WGS
AF:
0.124
AC:
432
AN:
3478
EpiCase
AF:
0.113
EpiControl
AF:
0.117

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteMay 28, 2020- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 07, 2011This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Andersen Tawil syndrome;C1865018:Short QT syndrome type 3 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Andersen Tawil syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Atrial fibrillation, familial, 9 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 24, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Short QT syndrome type 3 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.9
DANN
Benign
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs173135; hg19: chr17-68172326; COSMIC: COSV54660636; API